van Wyk V - Search Results

1

Transient interruption of arterial thrombosis by inhibition of factor Xa results in long-term antithrombotic effects in baboons.

Kotzé HF, Lamprecht S, Badenhorst PN, Roodt JP, van Wyk V. Kotzé HF, et al. Thromb Haemost. 1997 Jun;77(6):1137-42. Thromb Haemost. 1997. PMID: 9241746

2

In vivo inhibition of acute platelet-dependent thrombosis in a baboon model by Bay U3405, a thromboxane A2-receptor antagonist.

Kotzé HF, Lamprecht S, Badenhorst PN, van Wyk V, Roodt JP, Alexander K. Kotzé HF, et al. Thromb Haemost. 1993 Oct 18;70(4):672-5. Thromb Haemost. 1993. PMID: 8115994

3

Influence of platelet membrane sialic acid and platelet-associated IgG on ageing and sequestration of blood platelets in baboons.

Kotzé HF, van Wyk V, Badenhorst PN, Heyns AD, Roodt JP, Lötter MG. Kotzé HF, et al. Thromb Haemost. 1993 Oct 18;70(4):676-80. Thromb Haemost. 1993. PMID: 8115995

4

Antithrombotic activity of Bay u3405, a thromboxane A2-antagonist, in patients with Dacron aortic grafts: a random controlled clinical trial.

Pieters H, Roodt JP, Badenhorst PN, van Wyk V, Schall R, Lötter MG, Hundt HK, Nel CJ. Pieters H, et al. Thromb Haemost. 1993 Dec 20;70(6):903-8. Thromb Haemost. 1993. PMID: 8165609 Clinical Trial.

5

Prolonged inhibition of acute arterial thrombosis by high dosing of a monoclonal anti-platelet glycoprotein IIb/IIIa antibody in a baboon model.

Kotzé HF, Badenhorst PN, Lamprecht S, Meiring M, Van Wyk V, Nuyts K, Stassen JM, Vermylen J, Deckmyn H. Kotzé HF, et al. Thromb Haemost. 1995 Aug;74(2):751-7. Thromb Haemost. 1995. PMID: 8585017

6

r-Hirudin inhibits platelet-dependent thrombosis during cardiopulmonary bypass in baboons.

van Wyk V, Neethling WM, Badenhorst PN, Kotzé HF. van Wyk V, et al. J Cardiovasc Surg (Torino). 1998 Oct;39(5):633-9. J Cardiovasc Surg (Torino). 1998. PMID: 9833724

7

The effect of monoclonal anti-human-platelet antibodies on platelet kinetics in a baboon model: IgG subclass dependency.

Coetzee LM, Pieters H, van Wyk V, Cooper S, Roodt J, De Reys S, Badenhorst PN. Coetzee LM, et al. Among authors: van wyk v. Thromb Haemost. 2000 Jan;83(1):148-56. Thromb Haemost. 2000. PMID: 10669169

8

Determination of the dosage of recombinant hirudin to inhibit arterial thrombosis in baboons.

Kotzé HF, Lamprecht S, Van Wyk V, Roodt JP, Badenhorst PN. Kotzé HF, et al. Among authors: van wyk v. J Pharm Sci. 2000 May;89(5):579-85. doi: 10.1002/(SICI)1520-6017(200005)89:5<579::AID-JPS3>3.0.CO;2-1. J Pharm Sci. 2000. PMID: 10756323

9

In vitro effect of a thrombin inhibition peptide selected by phage display technology.

Meiring MS, Litthauer D, Hársfalvi J, van Wyk V, Badenhorst PN, Kotzé HF. Meiring MS, et al. Among authors: van wyk v. Thromb Res. 2002 Sep 15;107(6):365-71. doi: 10.1016/s0049-3848(02)00349-3. Thromb Res. 2002. PMID: 12565725

10

The sensitivity of tests to detect in vivo platelet activation induced by the removal of arterial endothelium of the baboon (Papio ursinus).

Kotzé HF, Heyns AD, van Wyk V, Steyn JG, Duyvené de Wit LJ, Badenhorst PN. Kotzé HF, et al. S Afr Med J. 1990 Sep 1;78(5):271-6. S Afr Med J. 1990. PMID: 2392725

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

26 results

Search Page

Filters